Table 1.
Pharmacogenomics in the renin-angiotensin system (RAS): Studies of blood pressure response to RAS blockade among genetic variants
Study | Year | Area | Ethnicity | Patients, N | Drug class | Drug | Genetic variant of the RAS | Significant difference? |
---|---|---|---|---|---|---|---|---|
Nordestgaard et al. [24••] | 2010 | Scandinavia | White (92%) | 1,774 | ARB | Losartan | ACE (I/D) | No |
AGT (M235T) | No | |||||||
AT1 (A1166C) | No | |||||||
Konoshita et al. [25••] | 2009 | Japan | Japanese (100%) | 231 | ARB | Valsartan | ACE (I/D) | No |
AGT (M235T) | No | |||||||
AT1 (A1166C) | No | |||||||
AT2 (C3123A) | No | |||||||
REN (C-5312T) | Yes | |||||||
Redon et al. [26] | 2005 | Spain | Spanish (100%)? | 206 | ARB | Telmisartan | ACE (I/D) | No |
AGT (A-6G) | No | |||||||
AT1 (A1166C, | No | |||||||
C573T) | No | |||||||
Yu et al. [33] | 2009 | China | Chinese (100%) | 509 | ACEI | Imidapril or benazepril | AT1 (A1166C) | No |
Filigheddu et al. [27] | 2008 | Italy (North Sardinia) | White (100%) | 191 | ACEI | Fosinopril | ACE (I/D) | No |
AGT (A-6G) | No | |||||||
AT1 (A1166C) | No | |||||||
Fan et al. [43] | 2007 | China | Chinese (100%) | 624 | ACEI | Captopril | ACE2 (rs2106809) | Yes |
Brunner et al. [34] | 2007 | USA | White (35%) | 551 | ACEI | Trandolapril | AT1 (A1166C) | No |
Hispanic (44%) | ||||||||
Su et al. [32] | 2007 | China (Shanghai) | Chinese (100%) | 1,447 | ACEI | Benazepril | AGT (multi loci) | Yes |
AT1 (multi loci) | Yes | |||||||
AT2 (multi loci) | No | |||||||
Arnett et al. [28] | 2005 | USA | White (61%) | 7,528 | ACEI | Lisinopril | ACE (I/D) | No |
Black (35%) | ||||||||
Yu et al. [31] | 2005 | China | Chinese (100%) | 501 | ACEI | Imidapril or benazepril | AGT (M235T) | No |
Yu et al. [29] | 2003 | China | Chinese (100%) | 517 | ACEI | Imidapril or benazepril | ACE (I/D) | No |
ARB angiotensin receptor blocker; ACE angiotensin-converting enzyme, ACEI ACE inhibitor; ACE (I/D) insertion and deletion genetic variant of intron 16; AGT angiotensinogen; AT1 angiotensin II type 1 receptor; AT2 angiotensin II type 2 receptor; REN renin